Clinical significance of antinuclear matrix antibody in serum from patients with anti-U1RNP antibody

Archives of Dermatological Research

Volumn 292, Issue 2-3, 2000, Pages 55-59

  Sato, Shinichi ^a   Hasegawa, Minoru ^a   Ihn, Hironobu ^b   Kikuchi, Kanako ^b   Takehara, Kazuhiko ^a  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Anti U1RNP antibody; Antinuclear matrix antibody; Mixed connective tissue disease; Systemic sclerosis

Indexed keywords

ANTINUCLEAR ANTIBODY; CARBON MONOXIDE; RIBONUCLEOPROTEIN ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY TITER; ARTICLE; CELL NUCLEUS MATRIX; CLINICAL ARTICLE; CONNECTIVE TISSUE DISEASE; FEMALE; FINGER; GAS DIFFUSION; HUMAN; JAPAN; MALE; MIXED CONNECTIVE TISSUE DISEASE; PHALANX; PRIORITY JOURNAL; SKIN SCAR; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

EID: 0034019041     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004030050010     Document Type: Article

References (31)

1. Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR (1972) Mixed connective tissue disease - an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 52: 148-159
2. Smolen JS, Steiner G (1998) Mixed connective tissue disease: to be or not to be. Arthritis Rheum 41:768-777
3. Sharp GC, Irvin WS, May CM, Holman HR, McDuffie FC, Hess EV, Schmid FR (1976) Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systemic lupus erythematosus and other rheumatic diseases. New Engl J Med 295:1149-1154
4. Lemmer JP, Curry NH, Mallory JH, Waller MV (1982) Clinical characteristics and course in patients with high titer anti-RNP antibodies. J Rheumatol 9:536-542
5. Munves EF, Shur PH (1983) Antibodies to Sm and RNP: prognosticators of disease involvement. Arthritis Rheum 26:848-853
6. Gaudreau A, Amor B, Kahn MF, Ryckewaert A, Sany J, Peltier AP (1978) Clinical significance of antibodies to soluble extractable nuclear antigens (anti-ENA). Ann Rheum Dis 37: 321-327
7. Reichlin M, Mattioli M (1972) Correlation of a precipitin reaction to an RNAprotein antigen and a low prevalence of nephritis in patients with systemic lupus erythematosus. New Engl J Med 286:908-911
8. Reichlin M (1976) Problems in differentiating SLE and mixed connective-tissue disease. New Engl J Med 295:1194-1195
9. Nimelstein SH, Brody S, Mcshane D, Holman HR (1980) Mixed connective tissue disease: a subsequent evaluation of the original 25 patients. Medicine 59:239-248
10. Notman DD, Kurata N, Tan EM (1975) Profiles of antinuclear antibodies in systemic rheumatic diseases. Ann Intern Med 83: 464-469
11. Lazaro MA, Maldonado Cocco JA, Catoggio LJ, Babini SM, Messina OD, Morteo OG (1989) Clinical and serologic characteristics of patients with overlap syndrome: is mixed connective tissue disease a distinct clinical entity? Medicine 68:58-65
12. Combe B, Rucheton M, Graafland H, Lussiez V, Brunel C, Sany J (1989) Clinical significance of anti-RNP and anti-Sm autoantibodies as determined by immunoblotting and immunoprecipitation in sera from patients with connective tissue diseases. Clin Exp Immunol 75:18-24
13. Fritzler MJ, Ali R, Tan EM (1984) Antibodies from patients with mixed connective tissue disease react with heterogeneous nuclear ribonucleoprotein or ribonucleic acid (hnRNP/RNA) of the nuclear matrix. J Immunol 132:1216-1222
14. Kasukawa R, Tojo T, Miyawaki S (1987) Preliminary diagnostic criteria for classification of mixed connective tissue disease. In: Kasukawa R, Sharp GC (eds) Mixed connective tissue diseases and antinuclear antibodies. Elsevier, Amsterdam, pp 41-47
15. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581-590
16. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277
17. Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292:403-408
18. Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344-348
19. Kuwana M, Okano Y, Kaburaki J, Inoko H (1996) Clinical correlation with HLA type in Japanese patients with connective tissue disease and anti-U1 small nuclear RNP antibodies. Arthritis Rheum 39:938-942
20. Sato S, Ihn H, Soma Y, Igarashi A, Tamaki T, Kikuchi K, Ishibashi Y, Takehara K (1993) Antihistone antibodies in patients with localized scleroderma. Arthritis Rheum 36:1137-1141
21. Verheijen R, Van Venrooij W, Ramaekers F (1988) The nuclear matrix: structure and composition. J Cell Sci 90:11-36
22. Deng J-S, Benedict L, Deng DH (1996) Significance of antinuclear matrix antibodies in patients with in vivo speckled antinuclear antibody staining. Arthritis Rheum 39:1300-1307
23. Amigues J-M, Cantagrel A, Abbal M, Mazieres B, The Autoimmunity Group of the Hospitals of Toulouse (1996) Comparative study of 4 diagnosis criteria sets for mixed connective tissue disease in patients with anti-RNP antibodies. J Rheumatol 23:2055-2062
24. Reichlin M, Van Venrooij WJ (1991) Autoantibodies to the URNP particles: relationship to clinical diagnosis and nephritis. Clin Exp Immunol 83:286-290
25. Vencovsky J, Williams DG, Field M, Maini RN (1993) Clinical associations of IgG antibodies to the ribonucleoprotein p67 polypeptide in patients with systemic lupus erythematosus. Ann Rheum Dis 51:1313-1317
26. Takeda Y, Wang GS, Wang RJ, Anderson SK, Pettersson I, Amaki S, Sharp GC (1989) Enzyme-linked immunosorbent assay using isolated (U) small nuclear ribonucleoprotein polypeptides as antigens to investigate the clinical significance of autoantibodies to these polypeptides. Clin Immunol Immunopathol 50:213-230
27. Netter HJ, Guldner HH, Szostecki C, Lakomek H-J, Will H (1988) A recombinant autoantigen derived from the human (U1) small nuclear RNP-specific 68-kd protein: expression in Escherichia coli and serodiagnostic application. Arthritis Rheum 31:616-622
28. St. Clair EW, Query CC, Bentley R, Keene JD, Polisson RP, Allen NB, Caldwell DS, Rice JR, Cox C, Pisetsky DS (1990) Expression of autoantibodies to recombinant (U1) RNP-associated 70 K antigen in systemic lupus erythematosus. Clin Immunol Immunopathol 54:266-280
29. McHugh N, James I, Maddison P (1990) Clinical significance of antibodies to a 68 kDa U1RNP polypeptide in connective tissue disease. J Rheumatol 17:1320-1328
30. Cram DS, Fisicaro N, Coppel RL, Whittingham S, Harrison LC (1990) Mapping of multiple B cell epitopes on the 70-kilodalton autoantigen of the U1 ribonucleoprotein complex. J Immunol 145:630-635
31. Habets WJ, Hoet MH, Venrooij WJ van (1990) Epitope patterns of anti-RNP antibodies in rheumatic diseases: evidence for an antigen-driven autoimmune response. Arthritis Rheum 33:834-841